참고문헌
- Weber, D. R., Haynes, K., Leonard, M. B., Willi, S. M. & Denburg, M. R. Type 1 diabetes is associated with an increased risk of fracture across the life span: a population-based cohort study using The Health Improvement Network (THIN). Diabetes Care 38, 1913-1920 (2015). https://doi.org/10.2337/dc15-0783
- Humphers, J. M., Shibuya, N., Fluhman, B. L. & Jupiter, D. The impact of glycosylated hemoglobin and diabetes mellitus on wound-healing complications and infection after foot and ankle surgery. J. Am. Podiatr. Med. Assoc. 104, 320-329 (2014). https://doi.org/10.7547/0003-0538-104.4.320
- Shibuya, N., Humphers, J. M., Fluhman, B. L. & Jupiter, D. C. Factors associated with nonunion, delayed union, and malunion in foot and ankle surgery in diabetic patients. J. Foot Ankle Surg. 52, 207-211 (2013). https://doi.org/10.1053/j.jfas.2012.11.012
- Dede, A. D., Tournis, S., Dontas, I. & Trovas, G. Type 2 diabetes mellitus and fracture risk. Metabolism 63, 1480-1490 (2014). https://doi.org/10.1016/j.metabol.2014.09.002
- Dogan, A. et al. A new hope for obesity management: boron inhibits adipogenesis in progenitor cells through the Wnt/beta-catenin pathway. Metabolism 69, 130-142 (2017). https://doi.org/10.1016/j.metabol.2017.01.021
- Tao, H., Yang, J. J., Shi, K. H. & Li, J. Wnt signaling pathway in cardiac fibrosis: new insights and directions. Metabolism 65, 30-40 (2016). https://doi.org/10.1016/j.metabol.2015.10.013
- Jin, T. The WNT signalling pathway and diabetes mellitus. Diabetologia 51, 1771-1780 (2008). https://doi.org/10.1007/s00125-008-1084-y
- Li, X. et al. Chemical and genetic evidence for the involvement of Wnt antagonist Dickkopf2 in regulation of glucose metabolism. Proc. Natl. Acad. Sci. USA 109, 11402-11407 (2012). https://doi.org/10.1073/pnas.1205015109
- Rulifson, I. C. et al. Wnt signaling regulates pancreatic beta cell proliferation. Proc. Natl. Acad. Sci. USA 104, 6247-6252 (2007). https://doi.org/10.1073/pnas.0701509104
- Fujino, T. et al. Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion. Proc. Natl. Acad. Sci. USA 100, 229-234 (2003). https://doi.org/10.1073/pnas.0133792100
- Hie, M., Iitsuka, N., Otsuka, T. & Tsukamoto, I. Insulin-dependent diabetes mellitus decreases osteoblastogenesis associated with the inhibition of Wnt signaling through increased expression of Sost and Dkk1 and inhibition of Akt activation. Int. J. Mol. Med. 28, 455-462 (2011).
- Hie, M., Yamazaki, M. & Tsukamoto, I. Curcumin suppresses increased bone resorption by inhibiting osteoclastogenesis in rats with streptozotocininduced diabetes. Eur. J. Pharmacol. 621, 1-9 (2009). https://doi.org/10.1016/j.ejphar.2009.08.025
- Reni, C., Mangialardi, G., Meloni, M. & Madeddu, P. Diabetes stimulates osteoclastogenesis by acidosis-induced activation of transient receptor potential cation channels. Sci. Rep. 6, 30639 (2016). https://doi.org/10.1038/srep30639
- Monroe, D. G., McGee-Lawrence, M. E., Oursler, M. J. & Westendorf, J. J. Update on Wnt signaling in bone cell biology and bone disease. Gene 492, 1-18 (2012). https://doi.org/10.1016/j.gene.2011.10.044
- Lopez-Herradon, A. et al. Inhibition of the canonical Wnt pathway by high glucose can be reversed by parathyroid hormone-related protein in osteoblastic cells. J. Cell Biochem. 114, 1908-1916 (2013). https://doi.org/10.1002/jcb.24535
- Portal-Nunez, S. et al. Alterations of the Wnt/beta-catenin pathway and its target genes for the N- and C-terminal domains of parathyroid hormonerelated protein in bone from diabetic mice. FEBS Lett. 584, 3095-3100 (2010). https://doi.org/10.1016/j.febslet.2010.05.047
- Li, L. et al. Acceleration of bone regeneration by activating Wnt/beta-catenin signalling pathway via lithium released from lithium chloride/calcium phosphate cement in osteoporosis. Sci. Rep. 7, 45204 (2017). https://doi.org/10.1038/srep45204
- Yee, C. S. et al. Sclerostin antibody treatment improves fracture outcomes in a Type I diabetic mouse model. Bone 82, 122-134 (2016). https://doi.org/10.1016/j.bone.2015.04.048
- Seeman, E. Age- and menopause-related bone loss compromise cortical and trabecular microstructure. J. Gerontol. A Biol. Sci. Med. Sci. 68, 1218-1225 (2013). https://doi.org/10.1093/gerona/glt071
- Szabo, M. E., Zekonyte, J., Katsamenis, O. L., Taylor, M. & Thurner, P. J. Similar damage initiation but different failure behavior in trabecular and cortical bone tissue. J. Mech. Behav. Biomed. Mater. 4, 1787-1796 (2011). https://doi.org/10.1016/j.jmbbm.2011.05.036
- Weatherholt, A. M., Fuchs, R. K. & Warden, S. J. Cortical and trabecular bone adaptation to incremental load magnitudes using the mouse tibial axial compression loading model. Bone 52, 372-379 (2013). https://doi.org/10.1016/j.bone.2012.10.026
- Behrendt, A. K. et al. Dietary restriction-induced alterations in bone phenotype: effects of lifelong versus short-termcaloric restriction on femoral and vertebral bone in C57BL/6 mice. J. Bone Miner. Res. 31, 852-863 (2016). https://doi.org/10.1002/jbmr.2745
- Iwamoto, J., Sato, Y. & Matsumoto, H. Influence of gastrectomy on cortical and cancellous bones in rats. Gastroenterol. Res. Pract. 2013, 381616 (2013).
- Karim, L., Tang, S. Y., Sroga, G. E. & Vashishth, D. Differences in non-enzymatic glycation and collagen cross-links between human cortical and cancellous bone. Osteoporos. Int. 24, 2441-2447 (2013). https://doi.org/10.1007/s00198-013-2319-4
- Li, Z. et al. In vivo monitoring of bone architecture and remodeling after implant insertion: the different responses of cortical and trabecular bone. Bone 81, 468-477 (2015). https://doi.org/10.1016/j.bone.2015.08.017
- Tottrup, M. et al. Pharmacokinetics of cefuroxime in porcine cortical and cancellous bone determined by microdialysis. Antimicrob. Agents Chemother. 58, 3200-3205 (2014). https://doi.org/10.1128/AAC.02438-14
- Li, J. et al. Different bone remodeling levels of trabecular and cortical bone in response to changes in Wnt/beta-catenin signaling in mice. J. Orthop. Res. 35, 812-819 (2017). https://doi.org/10.1002/jor.23339
- Bennett, C. N. et al. Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation. J. Bone Miner. Res. 22, 1924-1932 (2007). https://doi.org/10.1359/jbmr.070810
- Maeda, K. et al. Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis. Nat. Med. 18, 405-412 (2012). https://doi.org/10.1038/nm.2653
- Moverare-Skrtic, S. et al. Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures. Nat. Med. 20, 1279-1288 (2014). https://doi.org/10.1038/nm.3654
- Bao, Q. et al. An appropriate Wnt/beta-catenin expression level during the remodeling phase is required for improved bone fracture healing in mice. Sci. Rep. 7, 2695 (2017). https://doi.org/10.1038/s41598-017-02705-0
- Bao, Q. et al. Constitutive beta-catenin activation in osteoblasts impairs terminal osteoblast differentiation and bone quality. Exp. Cell Res. 350, 123-131 (2017). https://doi.org/10.1016/j.yexcr.2016.11.013
- Zhong, Z. A. et al. Optimizing tamoxifen-inducible Cre/loxp system to reduce tamoxifen effect on bone turnover in long bones of young mice. Bone 81, 614-619 (2015). https://doi.org/10.1016/j.bone.2015.07.034
- Chen, S. et al. Adverse effects of osteocytic constitutive activation of ss-Catenin on bone strength and bone growth. J. Bone Miner. Res. 30, 1184-1194 (2015). https://doi.org/10.1002/jbmr.2453
- Bouxsein, M. L. et al. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J. Bone Miner. Res. 25, 1468-1486 (2010). https://doi.org/10.1002/jbmr.141
- Dempster, D. W. et al. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 28, 2-17 (2013). https://doi.org/10.1002/jbmr.1805
- Power, J. et al. Osteocyte lacunar occupancy in the femoral neck cortex: an association with cortical remodeling in hip fracture cases and controls. Calcif. Tissue Int. 69, 13-19 (2001). https://doi.org/10.1007/s00223-001-0013-6
- Mori, K. et al. Diabetic osteopenia by decreased beta-catenin signaling is partly induced by epigenetic derepression of sFRP-4 gene. PLoS ONE 9, e102797 (2014). https://doi.org/10.1371/journal.pone.0102797
- Krishnan, V., Bryant, H. U. & Macdougald, O. A. Regulation of bone mass by Wnt signaling. J. Clin. Invest. 116, 1202-1209 (2006). https://doi.org/10.1172/JCI28551
- Borah, B. et al. Risedronate reduces intracortical porosity in women with osteoporosis. J. Bone Miner. Res. 25, 41-47 (2010). https://doi.org/10.1359/jbmr.090711
- Bui, M. et al. Architecture of cortical bone determines in part its remodelling and structural decay. Bone 55, 353-358 (2013). https://doi.org/10.1016/j.bone.2013.04.020
- Burr, D. B. Cortical bone: a target for fracture prevention? Lancet 375, 1672-1673 (2010). https://doi.org/10.1016/S0140-6736(10)60444-8
- Naruse, K. et al. Alendronate does not prevent long bone fragility in an inactive rat model. J. Bone Miner. Metab. 34, 615-626 (2016). https://doi.org/10.1007/s00774-015-0714-y
- Zebaze, R. M. et al. Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study. Lancet 375, 1729-1736 (2010). https://doi.org/10.1016/S0140-6736(10)60320-0
- Shanbhogue, V. V. et al. Bone beometry, volumetric density, microarchitecture, and estimated bone strength assessed by HR-pQCT in adult patients with type 1 diabetes mellitus. J. Bone Miner. Res. 30, 2188-2199 (2015). https://doi.org/10.1002/jbmr.2573
- Saha, M. T., Sievanen, H., Salo, M. K., Tulokas, S. & Saha, H. H. Bone mass and structure in adolescents with type 1 diabetes compared to healthy peers. Osteoporos. Int. 20, 1401-1406 (2009). https://doi.org/10.1007/s00198-008-0810-0
- Verroken, C. et al. Cortical bone size eficit in adult patients with type 1 diabetes mellitus. J. Clin. Endocrinol. Metab. 102, 2887-2895 (2017). https://doi.org/10.1210/jc.2017-00620
- Graubert, M. D., Goldstein, S. & Phillips, L. S. Nutrition and somatomedin. XXVII. Total and free IGF-I and IGF binding proteins in rats with streptozocin-induced diabetes. Diabetes 40, 959-965 (1991). https://doi.org/10.2337/diab.40.8.959
- Romero, D. F. et al. Amylin increases bone volume but cannot ameliorate diabetic osteopenia. Calcif. Tissue Int. 56, 54-61 (1995). https://doi.org/10.1007/BF00298745
- Liang, J. & Slingerland, J. M. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2, 339-345 (2003).
- Tsentidis, C. et al. Increased levels of Dickkopf-1 are indicative of Wnt/betacatenin downregulation and lower osteoblast signaling in children and adolescents with type 1 diabetes mellitus, contributing to lower bone mineral density. Osteoporos. Int. 28, 945-953 (2017). https://doi.org/10.1007/s00198-016-3802-5
- Schaffler, M. B. & Burr, D. B. Stiffness of compact bone: effects of porosity and density. J. Biomech. 21, 13-16 (1988). https://doi.org/10.1016/0021-9290(88)90186-8
- Yeni, Y. N., Brown, C. U., Wang, Z. & Norman, T. L. The influence of bone morphology on fracture toughness of the human femur and tibia. Bone 21, 453-459 (1997). https://doi.org/10.1016/S8756-3282(97)00173-7
- Makras, P., Delaroudis, S. & Anastasilakis, A. D. Novel therapies for osteoporosis. Metabolism 64, 1199-1214 (2015). https://doi.org/10.1016/j.metabol.2015.07.011
- Kobayashi, Y. et al. Wnt16 regulates osteoclast differentiation in conjunction with Wnt5a. Biochem. Biophys. Res. Commun. 463, 1278-1283 (2015). https://doi.org/10.1016/j.bbrc.2015.06.102
- Hamada, Y. et al. Histomorphometric analysis of diabetic osteopenia in streptozotocin-induced diabetic mice: a possible role of oxidative stress. Bone 40, 1408-1414 (2007). https://doi.org/10.1016/j.bone.2006.12.057
- Ogawa, N. et al. The combination of high glucose and advanced glycation end-products (AGEs) inhibits the mineralization of osteoblastic MC3T3-E1 cells through glucose-induced increase in the receptor for AGEs. Horm. Metab. Res. 39, 871-875 (2007). https://doi.org/10.1055/s-2007-991157
- Weinberg, E., Maymon, T., Moses, O. & Weinreb, M. Streptozotocin-induced diabetes in rats diminishes the size of the osteoprogenitor pool in bone marrow. Diabetes Res. Clin. Pract. 103, 35-41 (2014). https://doi.org/10.1016/j.diabres.2013.11.015
- Iyer, S. et al. Deletion of FoxO1, 3, and 4 in osteoblast progenitors attenuates the loss of cancellous bone mass in a mouse model of type 1 diabetes. J. Bone Miner. Res. 32, 60-69 (2017). https://doi.org/10.1002/jbmr.2934
- Iyer, S. et al. FOXOs attenuate bone formation by suppressing Wnt signaling. J. Clin. Invest. 123, 3409-3419 (2013). https://doi.org/10.1172/JCI68049
피인용 문헌
- Doxycycline restores the impaired osteogenic commitment of diabetic-derived bone marrow mesenchymal stromal cells by increasing the canonical WNT signaling vol.518, pp.None, 2018, https://doi.org/10.1016/j.mce.2020.110975
- β-Catenin mediates glucose-dependent insulinotropic polypeptide increases in lysyl oxidase expression in osteoblasts vol.14, pp.None, 2021, https://doi.org/10.1016/j.bonr.2021.101063
- Role of osteogenic Dickkopf-1 in bone remodeling and bone healing in mice with type I diabetes mellitus vol.11, pp.1, 2021, https://doi.org/10.1038/s41598-021-81543-7
- The complex role of Wnt ligands in type 2 diabetes mellitus and related complications vol.25, pp.14, 2018, https://doi.org/10.1111/jcmm.16663